Literature DB >> 12400006

Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation.

Noélie Davezac1, Véronique Baldin, Joëlle Blot, Bernard Ducommun, Jean-Pierre Tassan.   

Abstract

The pEg3 protein is a member of the evolutionarily conserved KIN1/PAR-1/MARK kinase family which is involved in cell polarity and microtubule dynamics. In Xenopus, pEg3 has been shown to be a cell cycle dependent kinase whose activity increases to a maximum level during mitosis of the first embryonic cell division. CDC25B is one of the three CDC25 phosphatase genes identified in human. It is thought to regulate the G2/M progression by dephosphorylating and activating the CDK/cyclin complexes. In the present study we show that the human pEg3 kinase is able to specifically phosphorylate CDC25B in vitro. One phosphorylation site was identified and corresponded to serine 323. This residue is equivalent to serine 216 in human CDC25C which plays an important role in the regulation of phosphatase during the cell cycle and at the G2 checkpoint. pEg3 is also able to specifically associate with CDC25B in vitro and in vivo. We show that the ectopic expression of active pEg3 in human U2OS cells induces an accumulation of cells in G2. This effect is counteracted by overexpression of CDC25B. Taken together these results suggest that pEg3 is a potential regulator of the G2/M progression and may act antagonistically to the CDC25B phosphatase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12400006     DOI: 10.1038/sj.onc.1205870

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Spatial regulation of cytokinesis by the Kin1 and Pom1 kinases in fission yeast.

Authors:  Stéphanie La Carbona; Xavier Le Goff
Journal:  Curr Genet       Date:  2006-09-20       Impact factor: 3.886

2.  Murine protein serine-threonine kinase 38 activates p53 function through Ser15 phosphorylation.

Authors:  Hyun-A Seong; Hyunjung Ha
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

3.  Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells.

Authors:  Cenk Kig; Monique Beullens; Lijs Beke; Aleyde Van Eynde; Johannes T Linders; Dirk Brehmer; Mathieu Bollen
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

4.  MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.

Authors:  Gang Li; Mei Yang; Li Zuo; Mei-Xing Wang
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

5.  Cortical localization of maternal embryonic leucine zipper kinase (MELK) implicated in cytokinesis in early xenopus embryos.

Authors:  Jean-Pierre Tassan
Journal:  Commun Integr Biol       Date:  2011-07-01

6.  MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.

Authors:  Radoslav Janostiak; Navin Rauniyar; TuKiet T Lam; Jianhong Ou; Lihua J Zhu; Michael R Green; Narendra Wajapeyee
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

Review 7.  Molecular mechanisms of peritoneal dissemination in gastric cancer.

Authors:  Mitsuro Kanda; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

8.  Caenorhabditis elegans PIG-1/MELK acts in a conserved PAR-4/LKB1 polarity pathway to promote asymmetric neuroblast divisions.

Authors:  Shih-Chieh Chien; Eva-Maria Brinkmann; Jerome Teuliere; Gian Garriga
Journal:  Genetics       Date:  2012-12-24       Impact factor: 4.562

9.  Kin1 kinase localizes at the hyphal septum and is dephosphorylated by calcineurin but is dispensable for septation and virulence in the human pathogen Aspergillus fumigatus.

Authors:  Praveen R Juvvadi; D Christopher Cole; Katie Falloon; Greg Waitt; Erik J Soderblom; M Arthur Moseley; William J Steinbach
Journal:  Biochem Biophys Res Commun       Date:  2018-10-04       Impact factor: 3.575

10.  Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells.

Authors:  Ian M McDonald; Gavin D Grant; Michael P East; Thomas S K Gilbert; Emily M Wilkerson; Dennis Goldfarb; Joshua Beri; Laura E Herring; Cyrus Vaziri; Jeanette Gowen Cook; Michael J Emanuele; Lee M Graves
Journal:  J Biol Chem       Date:  2020-01-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.